Related references
Note: Only part of the references are listed.The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts
Hyunsoo Kim et al.
SCIENTIFIC REPORTS (2017)
Cell death and inflammation: the case for IL-1 family cytokines as the canonical DAMPs of the immune system
Seamus J. Martin
FEBS JOURNAL (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Poly-ADP-ribosylation-mediated degradation of ARTD1 by the NLRP3 inflammasome is a prerequisite for osteoclast maturation
C. Wang et al.
CELL DEATH & DISEASE (2016)
An NLRP3 Mutation Causes Arthropathy and Osteoporosis in Humanized Mice
John N. Snouwaert et al.
CELL REPORTS (2016)
NLRP3 mediates osteolysis through inflammation-dependent and -independent mechanisms
Chao Qu et al.
FASEB JOURNAL (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways
Chi-Ching Chang et al.
RHEUMATOLOGY (2015)
Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns
Liliana Schaefer
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response
Alberto Baroja-Mazo et al.
NATURE IMMUNOLOGY (2014)
Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging
Yun-Hee Youm et al.
CELL METABOLISM (2013)
Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation
Lyndsey Burton et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2013)
Protein Kinase C-Delta Deficiency Perturbs Bone Homeostasis by Selective Uncoupling of Cathepsin K Secretion and Ruffled Border Formation in Osteoclasts
Viviana Cremasco et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Osteocyte RANKL: New insights into the control of bone remodeling
Jinhu Xiong et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
TLR2/MyD88/NF-κB Pathway, Reactive Oxygen Species, Potassium Efflux Activates NLRP3/ASC Inflammasome during Respiratory Syncytial Virus Infection
Jesus Segovia et al.
PLOS ONE (2012)
Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice
Sheri L. Bonar et al.
PLOS ONE (2012)
IL-1 family cytokines trigger sterile inflammatory disease
John R. Lukens et al.
FRONTIERS IN IMMUNOLOGY (2012)
The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking
P. Leung et al.
BONE (2011)
Bisphosphonates: The first 40 years
R. Graham G. Russell
BONE (2011)
Development of micro-CT protocols for in vivo follow-up of mouse bone architecture without major radiation side effects
K. Laperre et al.
BONE (2011)
Genetic and Molecular Basis of Inflammasome-mediated Disease
Hal M. Hoffman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3 Inflammasome In Vitro
Borbala Pazar et al.
JOURNAL OF IMMUNOLOGY (2011)
Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling
Marcus Watkins et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Mediators of the inflammatory response to joint replacement devices
Neil Cobelli et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis
H. Clarke Anderson et al.
LABORATORY INVESTIGATION (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Seth L. Masters et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Inflammasome-Mediated Disease Animal Models Reveal Roles for Innate but Not Adaptive Immunity
Susannah D. Brydges et al.
IMMUNITY (2009)
NLRP3/Cryopyrin Is Necessary for Interleukin-1β (IL-1β) Release in Response to Hyaluronan, an Endogenous Trigger of Inflammation in Response to Injury
Kenshi Yamasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
A Novel, Highly Selective, Tight Binding IκB Kinase-2 (IKK-2) Inhibitor: A Tool to Correlate IKK-2 Activity to the Fate and Functions of the Components of the Nuclear Factor-κB Pathway in Arthritis-Relevant Cells and Animal Models
Gabriel Mbalaviele et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
T cells potentiate PTH-induced cortical bone loss through CD40L signaling
Yuhao Gao et al.
CELL METABOLISM (2008)
Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA)
Suvimol Chirathivat Hill et al.
PEDIATRIC RADIOLOGY (2007)
TNFα and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics
JC Dai et al.
BONE (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-α
T Ma et al.
CYTOKINE (2004)
The IκB function of NF-κB2 p100 controls stimulated osteoclastogenesis
DV Novack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis
K Kawana et al.
CLINICA CHIMICA ACTA (2002)
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts
S Takeshita et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Fibroblastic stromal cells express receptor activator of NF-κB ligand and support osteoclast differentiation
JMW Quinn et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
